Objectives: There is a known relationship between abdominal aortic aneurysms (AAA) and thoracic aortic aneurysms (TAAs), but the exact prevalence has not been determined. This study quantifies the prevalence of TAAs in patients with known AAAs.
Conclusions: TAAs seem to occur concomitantly with AAAs with significant frequency. Women seem to have a larger TAA diameter than men, despite smaller size AAA at diagnosis. This data supports obtaining a chest CT scan in all patients who present with an AAA. Methods: Vizient is based on International Classification of Diseases, 9th edition (ICD-9) procedure codes (38.34, 38.44, 38.64, 39.52, 39.71, 39.77, 39 .78) whereas the VQI includes both Current Procedural Terminology and ICD-9 procedure codes (38.44, 39.71) and further exclusionary criteria are applied before reporting (mycotic aneurysms, suprarenal anastomoses, fenestrated grafts, and redo open repair). Institutional data was obtained through electronic medical record query of relevant ICD-9 codes, cross-check of reported VQI and Vizient procedures, and supplemented by retrospective chart review. Dates of inclusion were April 1, 2011, to September 30, 2015, to match available data and exclude post-ICD-10 reporting. Subsequent exclusions were performed by filtering Vizient data for relevant ICD-9 diagnosis criteria (441.3, 441.4). The VQI and Vizient datasets were compared across equivalent outcome variables.
Results: The Vizient query resulted in 335 cases while VQI resulted in 336. There were no significant differences between Vizient and VQI in patient age (71.71 6 9.85 vs 71.16 6 8.94; P ¼ .78), sex (22.09% vs 22.92% female; P ¼ .79), or ethnicity (0.6% vs 1.49% Hispanic/Latino; P ¼ .26). There were no significant differences in reported patient race for black (4.78% vs 4.46%; P ¼ .51), white (85.67% vs 90.18%; P ¼ .07), and Asian (0.3% vs 0.3%, P¼1.00). Reported primary insurer differed significantly between Vizient and VQI, including Medicare (78.81% vs 70.19%; P ¼ .01), Medicaid (3.58% vs 1.13%; P ¼ .0365), and commercial (9.55% vs 3.02%; P ¼ .0005). With outcomes measures, both total duration of stay (7.53 6 9.09 days vs 9.76 6 13.62 days; P ¼ .0064) and intensive care duration of stay (3.21 6 5.12 days vs 4.99 6 9.02 days; P ¼ .0008) were significantly longer in VQI. Percentage of surgeries performed in 2015 was significantly higher in VQI (9.25% vs 15.48%; P ¼ .01), although they did not differ significantly between 2011 and 2014. Rates of EVAR use were significantly higher in VQI (36.41% vs 45.83%; P ¼ .01) whereas open repair rates did not differ significantly (54.62% vs 54.17%; P ¼ .91). Inpatient mortality did not differ significantly between Vizient and VQI (3.58% vs 2.98%; P ¼ .505). Disposition to home (78.21% vs 76.49%; P ¼ .5949) and to inpatient hospital (1.79% vs 1.49%; P ¼ .7598) did not differ while disposition to rehabilitation (4.48% vs 17.56%, P < .0001) and to nursing home (11.94% vs 1.49%, P < .0001) did differ significantly between Vizient and VQI.
Conclusions: Our study reveals significant reporting differences of demographics and outcomes between a national administrative database (Vizient) and national clinical registry (VQI) when evaluating at the institutional level. Future studies will individually validate datasets against retrospectively collected institutional data and standardize outcomes measures within Vizient and VQI datasets to observe any correction in discrepancies in quality measures and outcomes. 
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